Viewing Study NCT00854204

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:07 PM
Ignite Modification Date: 2026-03-06 @ 2:31 PM
Study NCT ID: NCT00854204
Status: COMPLETED
Last Update Posted: 2010-04-28
First Post: 2009-01-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Innovation-TiFP4-C101: A Study to Evaluate the Pharmacokinetics of TMC114 and TMC41629 After a Single Oral Dose of 2 Controlled-release Coformulations as Compared to an Immediate-release Coformulation of TMC114/TMC41629
Sponsor: Tibotec Pharmaceuticals, Ireland
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV-I View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Innovation-TiFP4-C101 View
None Innovation-C101 View
None Innovation View
None TMC114/TMC41629 View
None controlled-release coformulations View
None immediate-release coformulation View
None Pharmacokinetics View